Transcatheter aortic valve replacement with corevalve

Cardiology Clinics

Volumn 31, Issue 3, 2013, Pages 351-361

  Matthews, Ray V ^a   Shavelle, David M ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Aortic stenosis; CoreValve; Heart valve; Percutaneous; TAVI; TAVR

Indexed keywords

AORTA STENOSIS; AORTA VALVE PROSTHESIS; AORTIC VALVE REPAIR; BALLOON AORTIC VALVULOPLASTY; CALCIFICATION; CARDIOPULMONARY BYPASS; CARDIOVASCULAR MORTALITY; CEREBROVASCULAR ACCIDENT; CORONARY SINUS; DISEASE SEVERITY; HEART PACING; HUMAN; PRIORITY JOURNAL; REVIEW; TRANSCATHETER AORTIC VALVE IMPLANTATION; VASCULAR ACCESS;

AORTIC STENOSIS; COREVALVE; HEART VALVE; PERCUTANEOUS; TAVI; TAVR;

AGED, 80 AND OVER; AORTIC VALVE STENOSIS; BALLOON VALVULOPLASTY; CARDIAC CATHETERIZATION; HEART VALVE PROSTHESIS; HEART VALVE PROSTHESIS IMPLANTATION; HUMANS; MULTICENTER STUDIES AS TOPIC; PROSTHESIS DESIGN; RANDOMIZED CONTROLLED TRIALS AS TOPIC; REGISTRIES; STENTS;

EID: 84881358849     PISSN: 07338651     EISSN: 15582264     Source Type: Journal    
DOI: 10.1016/j.ccl.2013.05.007     Document Type: Review

References (46)

1. Gilard M., Eltchaninoff H., Iung B., et al. Registry of transcatheter aortic-valve implantation in high-risk patients. NEngl J Med 2012, 366(18):1705-1715.
2. Bonow R.O., Carabello B.A., Chatterjee K., et al. 2008 focused update incorporated into the ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to revise the 1998 guidelines for the management of patients with valvular heart disease). Endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. JAm Coll Cardiol 2008, 52(13):e1-e142.
3. Ross J., Braunwald E. Aortic stenosis. Circulation 1968, 38(Suppl 1):61-67.
4. Dweck M.R., Boon N.A., Newby D.E. Calcific aortic stenosis: a disease of the valve and the myocardium. JAm Coll Cardiol 2012, 60(19):1854-1863.
5. Cribier A., Savin T., Saoudi N., et al. Percutaneous transluminal valvuloplasty of acquired aortic stenosis in elderly patients: an alternative to valve replacement?. Lancet 1986, 1(8472):63-67.
6. Otto C.M., Mickel M.C., Kennedy J.W., et al. Three-year outcome after balloon aortic valvuloplasty. Insights into prognosis of valvular aortic stenosis. Circulation 1994, 89(2):642-650.
7. Bouma B.J., van Den Brink R.B., van Der Meulen J.H., et al. To operate or not on elderly patients with aortic stenosis: the decision and its consequences. Heart 1999, 82(2):143-148.
8. Iung B., Cachier A., Baron G., et al. Decision-making in elderly patients with severe aortic stenosis: why are so many denied surgery?. Eur Heart J 2005, 26(24):2714-2720.
9. Andersen H.R., Knudsen L.L., Hasenkam J.M. Transluminal implantation of artificial heart valves. Description of a new expandable aortic valve and initial results with implantation by catheter technique in closed chest pigs. Eur Heart J 1992, 13(5):704-708.
10. Bonhoeffer P., Boudjemline Y., Saliba Z., et al. Transcatheter implantation of a bovine valve in pulmonary position: a lamb study. Circulation 2000, 102(7):813-816.
11. Cribier A., Eltchaninoff H., Bash A., et al. Percutaneous transcatheter implantation of an aortic valve prosthesis for calcific aortic stenosis: first human case description. Circulation 2002, 106(24):3006-3008.
12. Leon M.B., Smith C.R., Mack M., et al. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. NEngl J Med 2010, 363(17):1597-1607.
13. Achenbach S., Schuhback A., Min J.K., et al. Determination of the aortic annulus plane in CT imaging-a step-by-step approach. JACC Cardiovasc Imaging 2013, 6(2):275-278.
14. Kasel A.M., Cassese S., Leber A.W., et al. Fluoroscopy-guided aortic Root imaging for TAVR: "Follow the right cusp" rule. JACC Cardiovasc Imaging 2013, 6(2):274-275.
15. Lal P., Upasani P., Kanwar S., et al. First-in-man experience of percutaneous aortic valve replacement using self-expanding corevalve prosthesis. Indian Heart J 2011, 63(3):241-244.
16. Grube E., Laborde J.C., Gerckens U., et al. Percutaneous implantation of the CoreValve self-expanding valve prosthesis in high-risk patients with aortic valve disease: the Siegburg first-in-man study. Circulation 2006, 114(15):1616-1624.
17. Grube E., Schuler G., Buellesfeld L., et al. Percutaneous aortic valve replacement for severe aortic stenosis in high-risk patients using the second- and current third-generation self-expanding CoreValve prosthesis: device success and 30-day clinical outcome. JAm Coll Cardiol 2007, 50(1):69-76.
18. Marcheix B., Lamarche Y., Berry C., et al. Surgical aspects of endovascular retrograde implantation of the aortic CoreValve bioprosthesis in high-risk older patients with severe symptomatic aortic stenosis. JThorac Cardiovasc Surg 2007, 134(5):1150-1156.
19. Tamburino C., Capodanno D., Mule M., et al. Procedural success and 30-day clinical outcomes after percutaneous aortic valve replacement using current third-generation self-expanding CoreValve prosthesis. JInvasive Cardiol 2009, 21(3):93-98.
20. Piazza N., Grube E., Gerckens U., et al. Procedural and 30-day outcomes following transcatheter aortic valve implantation using the third generation (18Fr) corevalve revalving system: results from the multicentre, expanded evaluation registry 1-year following CE mark approval. EuroIntervention 2008, 4(2):242-249.
21. Moat N.E., Ludman P., de Belder M.A., et al. Long-term outcomes after transcatheter aortic valve implantation in high-risk patients with severe aortic stenosis: the U.K. TAVI (United Kingdom Transcatheter Aortic Valve Implantation) Registry. JAm Coll Cardiol 2011, 58(20):2130-2138.
22. Linke A. 1-year outcome in real-world patients treated with TAVI: the ADVANCE study 2011, EuroPCR, Paris, 5-21-2013.
23. Tchetche D., van der Boon R.M., Dumonteil N., et al. Adverse impact of bleeding and transfusion on the outcome post-transcatheter aortic valve implantation: insights from the Pooled-RotterdAm-Milano-Toulouse in Collaboration Plus (PRAGMATIC Plus) initiative. Am Heart J 2012, 164(3):402-409.
24. Smith C.R., Leon M.B., Mack M.J., et al. Transcatheter versus surgical aortic-valve replacement in high-risk patients. NEngl J Med 2011, 364(23):2187-2198.
25. Schultz C.J., Weustink A., Piazza N., et al. Geometry and degree of apposition of the CoreValve ReValving system with multislice computed tomography after implantation in patients with aortic stenosis. JAm Coll Cardiol 2009, 54(10):911-918.
26. John D., Buellesfeld L., Yuecel S., et al. Correlation of Device landing zone calcification and acute procedural success in patients undergoing transcatheter aortic valve implantations with the self-expanding CoreValve prosthesis. JACC Cardiovasc Interv 2010, 3(2):233-243.
27. Moussa I.D. Complications of transcatheter aortic valve implantation with the CoreValve-what have we learned so far?. Catheter Cardiovasc Interv 2010, 76(5):767-768.
28. Piazza N., Lange R., Martucci G., et al. Patient selection for transcatheter aortic valve implantation: patient risk profile and anatomical selection criteria. Arch Cardiovasc Dis 2012, 105(3):165-173.
29. van Mieghem N.M., Nuis R.J., Piazza N., et al. Vascular complications with transcatheter aortic valve implantation using the 18 Fr Medtronic CoreValve System: the Rotterdam experience. EuroIntervention 2010, 5(6):673-679.
30. Piazza N., Serruys P.W., Lange R. Getting safely in and out of a transcatheter aortic valve implantation procedure vascular complications according to the valvular academic research consortium criteria. JACC Cardiovasc Interv 2011, 4(8):859-860.
31. Kappetein A.P., Head S.J., Genereux P., et al. Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document. JAm Coll Cardiol 2012, 60(15):1438-1454.
32. Lopez-Otero D., Munoz-Garcia A.J., Avanzas P., et al. Axillary approach for transcatheter aortic valve implantation: optimization of the endovascular treatment for the aortic valve stenosis. Rev Esp Cardiol 2011, 64(2):121-126.
33. Modine T., Obadia J.F., Choukroun E., et al. Transcutaneous aortic valve implantation using the axillary/subclavian access: feasibility and early clinical outcomes. JThorac Cardiovasc Surg 2011, 141(2):487-491. 491.e1.
34. Ruge H., Lange R., Bleiziffer S., et al. First successful aortic valve implantation with the CoreValve ReValving System via right subclavian artery access: a case report. Heart Surg Forum 2008, 11(5):E323-E324.
35. Bruschi G., Fratto P., De M.F., et al. The trans-subclavian retrograde approach for transcatheter aortic valve replacement: single-center experience. JThorac Cardiovasc Surg 2010, 140(4):911-915. 915.e1-2.
36. Bruschi G., De M.F., Botta L., et al. Direct transaortic CoreValve implantation through right minithoracotomy in patients with patent coronary grafts. Ann Thorac Surg 2012, 93(4):1297-1299.
37. Munoz-Garcia A.J., Hernandez-Garcia J.M., Jimenez-Navarro M.F., et al. Factors predicting and having an impact on the need for a permanent pacemaker after CoreValve prosthesis implantation using the new Accutrak delivery catheter system. JACC Cardiovasc Interv 2012, 5(5):533-539.
38. Liang M., Devlin G., Pasupati S. The incidence of transcatheter aortic valve implantation-related heart block in self-expandable Medtronic CoreValve and balloon-expandable Edwards valves. JInvasive Cardiol 2012, 24(4):173-176.
39. Khawaja M.Z., Rajani R., Cook A., et al. Permanent pacemaker insertion after CoreValve transcatheter aortic valve implantation: incidence and contributing factors (the UK CoreValve Collaborative). Circulation 2011, 123(9):951-960.
40. Jilaihawi H., Chakravarty T., Weiss R.E., et al. Meta-analysis of complications in aortic valve replacement: comparison of Medtronic-Corevalve, Edwards-Sapien and surgical aortic valve replacement in 8,536 patients. Catheter Cardiovasc Interv 2012, 80(1):128-138.
41. Buellesfeld L., Stortecky S., Heg D., et al. Impact of permanent pacemaker implantation on clinical outcome among patients undergoing transcatheter aortic valve implantation. JAm Coll Cardiol 2012, 60(6):493-501.
42. Miller D.C., Mack M., Svensson L.G., et al. Incidence, hazards, determinants and consequences of neurologic events after TAVR and AVR in the PARTNER Trial 2011, Transcatheter Valve Therapies, Vancouver (Canada).
43. Chieffo A., Buchanan G.L., van Mieghem N.M., et al. Transcatheter aortic valve implantation with the Edwards SAPIEN versus the Medtronic CoreValve Revalving system devices: a multicenter collaborative study: the PRAGMATIC Plus Initiative (Pooled-RotterdAm-Milano-Toulouse in Collaboration). JAm Coll Cardiol 2013, 61(8):830-836.
44. Szeto W.Y., Augoustides J.G., Desai N.D., et al. Cerebral embolic exposure during transfemoral and transapical transcatheter aortic valve replacement. JCard Surg 2011, 26(4):348-354.
45. Nietlispach F., Wijesinghe N., Gurvitch R., et al. An embolic deflection device for aortic valve interventions. JACC Cardiovasc Interv 2010, 3(11):1133-1138.
46. Ghanem A., Muller A., Nahle C.P., et al. Risk and fate of cerebral embolism after transfemoral aortic valve implantation: a prospective pilot study with diffusion-weighted magnetic resonance imaging. JAm Coll Cardiol 2010, 55(14):1427-1432.